WO2024108286A1 - Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso - Google Patents
Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso Download PDFInfo
- Publication number
- WO2024108286A1 WO2024108286A1 PCT/BR2023/050406 BR2023050406W WO2024108286A1 WO 2024108286 A1 WO2024108286 A1 WO 2024108286A1 BR 2023050406 W BR2023050406 W BR 2023050406W WO 2024108286 A1 WO2024108286 A1 WO 2024108286A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- composition
- lysate
- hair
- cosmetic
- animal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/10—Preparations for permanently dyeing the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Definitions
- the present invention describes a new composition for inducing melanin synthesis in an individual or animal, including its use for the prevention and/or reversal of the graying process of hair strands.
- the present invention is in the fields of cosmetic, dermatological and/or pharmaceutical treatments.
- the color of hair, as well as skin, is the result of the amount and type of melanin, produced by melanocytes and transferred to keratinocytes.
- Hair follicle pigmentation involves the melanogenic activity of follicular melanocytes, the transfer of melanin granules to cortical and medullary keratinocytes and the formation of pigmented hair shafts (SLOMINSKI et al., 2005).
- Gray hair is one of the most visible indicators of aging in humans.
- the modulation of the graying process results from numerous factors, such as genetic, oxidative, psycho-emotional, metabolic, endocrine and nutritional (O'SULLIVAN et al., 2021).
- gray hair is a phenomenon associated with a decrease in the population of follicular melanocytes and a decrease in melanin content (SARIN; ARTANDI, 2007).
- SARIN ARTANDI
- melanin content a phenomenon associated with a decrease in the population of follicular melanocytes and a decrease in melanin content
- SARIN ARTANDI
- melanosomes found in the cytoplasm of melanocytes.
- Melanocytes are derived from immature melanocytes. During embryogenesis, these cells migrate from the neural crest, a transient component of the ectoderm located between the neural tube and the epidermis, reach the basal layer of the epidermis and then enter the developing hair follicles (SLOMINSKI et al., 2005; TOBIN, 2008 ).
- MITF microphthalmia-associated transcription factor
- SOX10 transcription factor SOX10 transcription factor
- Pax3 protein KIT
- FGF-2 fibroblast growth factor-2
- endothelin 3 endothelin 3 and others
- the melanin produced is transferred from the melanocytes to the keratinocytes of the hair bulb (SLOMINSKI et al., 2005).
- Melanin is produced during a complex pathway involving a series of chemical and enzymatic reactions, known as melanogenesis.
- the color that constitutes an individual's hair is the result of the activity of the enzyme tyrosinase (TYR), so its regulation and activity are crucial during the melanin synthesis process (TOBIN, 2008).
- TRP-1 tyrosinase-related protein 1
- TRP-2 tyrosinase-related protein 2
- DCT dopachrome tautomerase
- the dopachrome it can then, by spontaneous decarboxylation, generate 5, 6-dihydroxyindole (DHI) which quickly oxidizes and polymerizes to form insoluble high molecular weight dark brown-black polymers, belonging to the group of eumelanins.
- DHI 5, 6-dihydroxyindole
- TRP-2/DCT is available, dopachrome can be acted upon by this enzyme and give rise to 5,6-dihydroxy-2-carboxylic acid (DHICA), which, through the action of TRP-1, will also form eumelanin.
- DHICA 5,6-dihydroxy-2-carboxylic acid
- cysteine In the presence of cysteine, dopaquinone reacts with this molecule, forming cystenyldopa, which then oxidizes and polymerizes, giving rise to soluble red-yellow pigments, collectively known as pheomelanins (PILLAIYAR et al., 2017).
- a-melanocyte-stimulating hormone (a-MSH) agonist such as GreyverseTM (Glycerin (and) Water (and ) Palmitoyl Tetrapeptide-20 Amide - IFF Lucas Meyer) - Patent Document AU2008271875A1 .
- GreyverseTM Glycerin (and) Water (and ) Palmitoyl Tetrapeptide-20 Amide - IFF Lucas Meyer
- Another example of a product consists of the association Taxifolina Glucoside and Acetyl Tyrosine (DarkenylTM - Givaudan) - Patent document W02020089216A1. According to the results presented, the product statistically significantly induces gene expression, among other genes, of MC1 R and POMC.
- EUK-134 Ethylbisiminomethylguaiacol Manganese Chloride - Lucas Meyer Cosmetics
- EUK-134 Ethylbisiminomethylguaiacol Manganese Chloride - Lucas Meyer Cosmetics
- CN102988235 describes the association of deer antler, Radix Ginseng Rubra Radix Polygoni Multiflori, Semen soyae atricolor, and Brassica campestris oil capable of promoting natural hair repigmentation.
- KR102265875 describes a composition intended for darkening hair and preventing graying using exosomes derived from stem cells.
- WO201 4096086 describes the topical use of the microorganism
- Bifidobacterium longum in lysate form, for pro-pigmenting action.
- PI0916690 discloses the oral cosmetic use of a probiotic microorganism (i.e., a live microorganism) of Lactobacillus paracasei or its lysate for cosmetic treatment of disorders of an oily scalp, particularly scalp dandruff.
- a probiotic microorganism i.e., a live microorganism
- Lactobacillus paracasei or its lysate for cosmetic treatment of disorders of an oily scalp, particularly scalp dandruff.
- KR102570587 describes the use of a product resulting from the fermentation of a microorganism of the genus Lactobacillus, that is, a mixture obtained from the fermentation of a culture medium containing an energy source such as skimmed milk powder with Lactobacillus to prevent gray hair or improve gray hair.
- a product resulting from the fermentation of a microorganism of the genus Lactobacillus that is, a mixture obtained from the fermentation of a culture medium containing an energy source such as skimmed milk powder with Lactobacillus to prevent gray hair or improve gray hair.
- the aforementioned document at no point describes the species of microorganism tested and which generated the experimental results, contenting itself with saying that it is a Lactobacillus culture selected from a total of 4,000 species (example 1).
- the strain may be one of Lactobacillus pentosus, Lactobacillus brevis, Lactobacillus plantarum, Lactobacillus casei and Lactobacillus acidophilus.
- the fermented product must contain a large amount of carboxyl groups, which react with the amino acid inside the hair strand to change the color of the strand through an external reaction to the fiber at room temperature. It is, therefore, not only a product of a different nature to the present invention, but also an agent that acts chemically on the thread, externally.
- the present invention aims to solve the constant problems in the state of the art using a new composition that surprisingly has a pro-melanogenesis effect.
- composition of the present invention showed results in inhibiting POM gene expression, in addition to decreasing the expression of MC1 R, both important biomarkers in the process of melanogenesis and, consequently, hair pigmentation. Furthermore, the composition of the present invention was shown to be capable of positively modulating the expression of other genes (e.g. TYR, DCT, TYRP-1, MITF, MYO5A, PMEL, MLPH), suggesting a different mechanism of action in relation to what is presented in the state of the art.
- other genes e.g. TYR, DCT, TYRP-1, MITF, MYO5A, PMEL, MLPH
- the composition comprises between 0.001% and 20% by weight of lysate.
- the composition comprises between 0.001% and 5% by weight of lysate. [0027] In one embodiment of the invention, the composition is for preventing and/or reversing the graying process of hair strands.
- the composition is for inducing melanin synthesis in hair follicles.
- the composition is a topical hair cosmetic composition.
- a new process for producing a composition as previously defined comprising: anaerobic cultivation of microorganisms of the species Lacticaseibacillus paracasei in culture medium until the stationary phase; total or partial inactivation and lysis of microorganisms by subjecting the medium to a temperature between 55°C and 80°C for at least 30 minutes; filtration and centrifugation; mixing the resulting lysate with at least one suitable cosmetic vehicle.
- a cosmetic method of inducing melanin synthesis in an individual or animal for preventing and/or reversing the graying process of hair strands comprising topical administration to the hair follicles of a composition as previously described, in a cosmetically suitable amount to enable said induction in an individual or animal.
- composition for inducing melanin synthesis in an individual or animal for preventing and/or reversing the graying process of hair strands is also presented.
- the composition is for application to a region of skin comprising hair follicles.
- Figure 1 Representative images of the effect of Lacticaseibacillus paracasei lysate on melanin synthesis in ex vivo hair follicles - Warthin Starry staining (x40 objective lens), comparatively the same formulation without the addition of the lysate (placebo) and a benchmark composition .
- the inventors characterized the ability of the Lacticaseibacillus paracasei lysate to stimulate the expression of a surprising number of genes related to melanin production in the hair follicle, in addition to directly demonstrating the stimulation of melanin melanin production in follicle culture.
- Lacticaseibacillus paracasei lysate was able to stimulate the gene expression of Tyrosinase (TYR), Dopachrome tautomerase (DCT), Tyrosinase-related Protein-1 (TYRP-1), Melanogenesis transcription factor -associated (MITF), Myosin 5A (MYO5A), Premelanosome Protein (PMEL), Melanophyllin (MLPH), all genes related to the pigmentation process in the hair follicle and skin.
- TLR Tyrosinase
- DCT Dopachrome tautomerase
- TYRP-1 Tyrosinase-related Protein-1
- MITF Melanogenesis transcription factor -associated
- PMEL Premelanosome Protein
- MLPH Melanophyllin
- the application of the cosmetic or dermatological or pharmaceutical compositions of the invention promotes the prevention and/or reversal of the hair graying process.
- the present invention refers to the use of a Lacticaseibacillus paracasei lysate or a fraction thereof for the preparation of a pharmaceutical and/or dermatological composition, intended for the prevention and/or reversal of hair graying process.
- the term “prevent” means to reduce the risk of manifestation of the phenomenon in question.
- a cosmetic method for treating and/or preventing the graying process comprising at least one step of administering a Lacticaseibacillus paracasei lysate or a fraction thereof to a individual in an effective quantity for the treatment and/or prevention in question.
- said lysate is applied topically to a region comprising hair follicles.
- Lacticaseibacillus paracasei also known as Lactobacillus paracasei (previous taxonomic definition of the microorganism and updated as described by Zheng et al. 2020 in the new taxonomic classification of the genus Lactobacillus in the specialized journal “International Journal of Systematic and Evolutionary Microbiology'), used as an active composition presented in the present patent application it is used in the form of a lysate.
- a lysate commonly denotes a material obtained after the destruction or dissolution of biological cells by a phenomenon called cell lysis, thus causing the release of intracellular biological constituents naturally contained in the cells of the microorganism in question.
- lysate is used to denote the entire lysate obtained by lysis of the microorganism in question or just a fraction of it.
- the invention relates to the application of a lysate of the species Lacticaseibacillus paracasei and/or a fraction thereof for the purposes specified herein.
- the lysate used is, therefore, formed totally or partially from intracellular biological constituents and/or constituents of cell walls and membranes.
- This cell lysis can be carried out by various technologies, for example osmotic shock, thermal shock, with ultrasound, or under mechanical stress such as centrifugation.
- the lysate is obtained by cell lysis between 55 S C and 80 S C, with centrifugation being carried out at the end of the process.
- microorganisms of the species Lacticaseibacillus paracasei are cultivated anaerobically in a suitable culture medium.
- the culture medium is inactivated and lysed, for example by heating to a temperature between 55°C and 80°C, optionally between 60°C and 65°C for 30 min by pasteurization process.
- the microorganisms are then removed by a conventional separation technique, for example membrane filtration, centrifuged and the supernatant is subsequently used as product.
- the active ingredient forming the lysate and belonging to the species Lacticaseibacillus paracasei can be formulated in a composition at a concentration of at least 0.0001% (expressed in dry weight), in particular at a concentration of 0.001 to 20% and more particularly at a concentration of 0.01 to 5% of the dry weight of the active substance in relation to the total weight of the vehicle or the composition that contains it.
- compositions according to the invention can be presented in all galenic forms normally available for the method of adopted administration.
- the carrier/vehicle can be of varied nature depending on the type of composition considered.
- compositions intended for topical administration may be an aqueous, aqueous-alcoholic or oily solution, a solution-type dispersion or lotion or serum-type dispersion, an emulsion of liquid or semi-liquid consistency, obtained by dispersing an oily phase in an aqueous phase (O/W) or vice versa (W/O), or a suspension or emulsion of soft, semi-solid or solid consistency, of the cream, aqueous or anhydrous gel type, or microemulsions, microcapsules, microparticles or vesicular dispersions of ionic and/or non-ionic type.
- the product formulation may be Benzyl alcohol: 0.80%; Ethylhexylglycerin: 0.20% and Lacticaseibacillus paracasei lysate: q.s.p 100%.
- compositions may in particular constitute creams for cleaning, protection, treatment or care, lotions, gels or mousses for scalp care, such as cleaning or disinfecting lotions or bath compositions. They can also be used for the scalp in the form of solutions, creams, gels, emulsions, mousses or in the form of aerosol compositions also containing a propellant under pressure. Specifically, they can be in the form of hair tonics, conditioners, leave ons, shampoos, among others.
- Said ingredient with anti-graying action has characteristics that allow it to be adapted into different types of products with different compositions for hair care, such as: [0060] Alcohol-free hair tonic, through compositions comprising 0.10% of xylyl sesquicaprylate, 2% PPG-5-Ceteth 20, 10% Lacticaseibacillus paracasei lysate and water q.s.p. 100%.
- compositions comprising 0.10% xylyl sesquicaprylate, 20% ethyl alcohol 96%, 2% of PPG-5-Ceteth 20, 10% Lacticaseibacillus paracasei lysate and 100% qsp water.
- Conditioner by means of compositions comprising 0.10% disodium EDTA, 1% glycerin, 0.50% cetyl trimethyl ammonium chloride, 0.22% 85% lactic acid, 3.00% alcohol keto-stearyl 30/70, 1.00% cetyl alcohol, 0.20% stearamido propyl dimethyl amine, 0.50% xilytyl sesquicaprylate, 2% Lacticaseibacillus paracasei lysate and water q.s.p. 100%.
- compositions comprising 0.10% disodium EDTA, 1% glycerin, 0.80% cetyl trimethyl ammonium chloride, 0.10% citric acid 50%, 0.22% lactic acid 85%, 3.00% keto-stearyl alcohol 30/70, 0.70% cetyl alcohol, 0.30% eyoxylated keto-stearyl alcohol 20 OE, 0.50% xylyl sesquicaprylate, 2% of Lacticaseibacillus paracasei lysate and water q.s.p. 100%.
- shampoo by means of compositions comprising 4% cocoamidopropylbetaine, 27% sodium lauryl ether sulfate, 3% sodium lauroyl sarcosinate, 1% laurel glucoside, 4% cocoamide DEA, 0.50% sesquicaprylate of xylyl, sodium chloride q.s.p, 50% citric acid solution q.s.p. pH 6.00 - 7.00, 2% Lacticaseibacillus paracase lysate in water q.s.p. 100%.
- dosage forms intended for topical administration may also contain additives common in the cosmetic, pharmaceutical and/or dermatological field, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active ingredients, preservatives, antioxidants, solvents, perfumes, fillers , filters, odor absorbers and dyes.
- additives common in the cosmetic, pharmaceutical and/or dermatological field, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active ingredients, preservatives, antioxidants, solvents, perfumes, fillers , filters, odor absorbers and dyes.
- additives common in the cosmetic, pharmaceutical and/or dermatological field, such as hydrophilic or lipophilic gelling agents, hydrophilic or lipophilic active ingredients, preservatives, antioxidants, solvents, perfumes, fillers , filters, odor absorbers and dyes.
- the quantities of these various additives are those classically used in the field in question, for example from 0.01 to 20% of the total weight of the composition. Depending on their nature, these
- the products can be used as cosmetic compositions, dermatological or pharmaceutical products for topical use capable of modulating the production of melanin in the hair follicle.
- These compositions may in particular constitute creams for cleaning, protection, treatment or care, lotions, gels, shampoos, conditioners or mousses for scalp care, such as cleaning or disinfecting lotions or bath compositions.
- Example 1 Assessment of the modulation of gene expression in fragments of human skin
- RNAIaterTM solution Qiagen
- the ex vivo tissue was mechanically macerated and then the RNA was extracted with a commercially available kit, quantified, and analyzed for its integrity.
- cDNA synthesis was performed with the High-Capacity cDNA Reverse Transcription® kit (Applied Biosystems) and conducted on the StepOnePlus device (Applied Biosystems). Subsequently, the cDNA was quantified in a Nanodrop Lite device (Thermo Scientific)
- High-throughput RT-qPCR was performed using the BiomarkTM HD System (Fluidigm, San Francisco, CA), associated with the IFC Controller HX, which supports the IFC 96.96 Dynamic ArrayTM.
- the cycle threshold was determined specifically for each assay using Fluidigm Software and expression results were analyzed using the delta-delta Ct method.
- Table 1 shows the average level of modulation of the expression of genes related to pigmentation in fragments treated with the Lacticaseibacillus paracasei lysate, in relation to the placebo group.
- Example 2 Evaluation of the induction of melanin synthesis in follicle culture
- lacticaseibacillus paracasei lysate 0.002% w/w
- benchmark Glycerin, Water and Palmitoyl Tetrapeptide-20 Amide - 0.002% w/w.
- an excess of hair follicles was prepared to reach the target value of 12 high-quality hair follicles per condition at the end of the experiment.
- the hair follicles were incubated for 7 days with renewal of the treatment by removing and replacing the medium after 3 and 5 days of incubation.
- the sections were deparaffinized and then subjected to the Warthin Starry staining method. Finally, the sections were observed under a microscope (40x objectives) and images were recorded. The amount of melanin was assessed by measuring the marked area of melanin normalized by the area of the bulb in the bulb (semiquantitative image analysis method).
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202380073489.2A CN120076785A (zh) | 2022-11-23 | 2023-11-22 | 用于诱导个人或动物内的黑色素合成的化妆品组合物、制备方法、美容方法和用途 |
| EP23892823.8A EP4623896A1 (en) | 2022-11-23 | 2023-11-22 | Cosmetic composition for inducing melanin synthesis in an individual or animal; production process; cosmetic method and use |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BR102022023843 | 2022-11-23 | ||
| BR1020220238430 | 2022-11-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2024108286A1 true WO2024108286A1 (pt) | 2024-05-30 |
Family
ID=91194784
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/BR2023/050406 Ceased WO2024108286A1 (pt) | 2022-11-23 | 2023-11-22 | Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP4623896A1 (pt) |
| CN (1) | CN120076785A (pt) |
| WO (1) | WO2024108286A1 (pt) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008271875A1 (en) | 2007-06-29 | 2009-01-08 | Clariant (Canada) Inc. | Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| WO2010013182A1 (en) | 2008-07-29 | 2010-02-04 | L'oreal | Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| WO2011070508A1 (en) * | 2009-12-08 | 2011-06-16 | L'oreal | Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion |
| CN102988235A (zh) | 2012-11-30 | 2013-03-27 | 浙江农林大学 | 一种天然黑发润发剂及其制备方法 |
| US8481299B2 (en) * | 2009-03-04 | 2013-07-09 | L'oreal | Use of probiotic microorganisms to limit skin irritation |
| WO2014096086A2 (fr) | 2012-12-21 | 2014-06-26 | L'oreal | Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine |
| US9782611B2 (en) * | 2008-10-28 | 2017-10-10 | L'oreal | Treatment of greasy skin with a bacterial lystate |
| WO2020089216A1 (en) | 2018-10-29 | 2020-05-07 | Givaudan Sa | Hair care active agent |
| KR102265875B1 (ko) | 2019-12-18 | 2021-06-17 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모발 흑화용, 모발 백화 방지용 또는 염모용 조성물 |
| KR102570587B1 (ko) | 2019-10-24 | 2023-08-28 | 주식회사 리즈케이 | 락토바실러스 발효물을 포함하는 모발 화장료 조성물 |
-
2023
- 2023-11-22 EP EP23892823.8A patent/EP4623896A1/en active Pending
- 2023-11-22 CN CN202380073489.2A patent/CN120076785A/zh active Pending
- 2023-11-22 WO PCT/BR2023/050406 patent/WO2024108286A1/pt not_active Ceased
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2008271875A1 (en) | 2007-06-29 | 2009-01-08 | Clariant (Canada) Inc. | Novel compounds, use thereof in cosmetic and cosmeceutic applications, and compositions comprising same |
| WO2010013182A1 (en) | 2008-07-29 | 2010-02-04 | L'oreal | Cosmetic use of microorganism(s) for the treatment of scalp disorders |
| BRPI0916690B1 (pt) * | 2008-07-29 | 2022-04-12 | L'oreal | Uso de uma quantidade eficaz de pelo menos um microorganismo probiótico, composição coméstica e/ou dermatólogica, método coméstico para tratar e/ou prevenir distúrbios estéticos do couro cabeludo em um indivíduo, processo cosmético para prevenir e/ou tratar uma condição de caspa do couro cabeludo, conjunto cosmético, e, uso cosmético de pelo menos uma quantidade eficaz de pelo menos um primeiro e um segundo agente cosmético ativo |
| US9782611B2 (en) * | 2008-10-28 | 2017-10-10 | L'oreal | Treatment of greasy skin with a bacterial lystate |
| US8481299B2 (en) * | 2009-03-04 | 2013-07-09 | L'oreal | Use of probiotic microorganisms to limit skin irritation |
| WO2011070508A1 (en) * | 2009-12-08 | 2011-06-16 | L'oreal | Probiotic microorganisms as active agents for enhancing the radiance of the skin's complexion |
| CN102988235A (zh) | 2012-11-30 | 2013-03-27 | 浙江农林大学 | 一种天然黑发润发剂及其制备方法 |
| WO2014096086A2 (fr) | 2012-12-21 | 2014-06-26 | L'oreal | Utilisation de microorganismes probiotiques comme agent favorisant la synthèse de mélanine |
| WO2020089216A1 (en) | 2018-10-29 | 2020-05-07 | Givaudan Sa | Hair care active agent |
| KR102570587B1 (ko) | 2019-10-24 | 2023-08-28 | 주식회사 리즈케이 | 락토바실러스 발효물을 포함하는 모발 화장료 조성물 |
| KR102265875B1 (ko) | 2019-12-18 | 2021-06-17 | 주식회사 엑소코바이오 | 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모발 흑화용, 모발 백화 방지용 또는 염모용 조성물 |
Non-Patent Citations (6)
| Title |
|---|
| BAJPAI, VK ET AL.: "Partially Purified Exo-Polysaccharide from Lactobacillus Sakei Probio 65 with Antioxidant, a - Glucosidase and Tyrosinase Inhibitory Potential", J. FOOD BIOCHEMISTRY, vol. 3, 2016, pages 264 - 274, XP055598313, DOI: 10.1111/jfbc.12230 |
| CHOI, W. S ET AL.: "Whitening Effects of Lactobacillus rhamnosus Associated with Its Antioxidative Activities", KOREAN J. MICROBIOL. BIOTECHNOL., vol. 41, no. 2, 2013, pages 183 - 189, XP053030590, DOI: 10.4014/kjmb.1302.02006 |
| KIM HR ET AL.: "Lipoteichoic acid isolated from Lactobacillus plantarum inhibits melanogenesis in B16F10 mouse melanoma cells", MOL CELLS, vol. 38, no. 2, 2015, pages 163 - 70 |
| LIM, HY ET AL.: "Antiwrinkle and Antimelanogenesis Effects of Tyndallized Lactobacillus acidophilus KCCM12625P", INT. J. MOL. SCI., vol. 21, 2020, pages 1620 |
| See also references of EP4623896A1 |
| ZHENG ET AL., INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY, 2020 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN120076785A (zh) | 2025-05-30 |
| EP4623896A1 (en) | 2025-10-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8709511B2 (en) | External preparation composition for skin comprising ginseng flower or ginseng seed extracts | |
| JP4971072B2 (ja) | 毛包メラノサイトの保護剤としてのドーパクローム異性化酵素(trp−2)活性を真似る薬剤の使用とその使用 | |
| CN113164797B (zh) | 聚伞岩蔷薇提取物的新型化妆品和皮肤病学用途 | |
| JP2004505007A (ja) | 抗グリケーション剤としての少なくとも1つのスノキ属植物の抽出物の使用 | |
| JP6387219B2 (ja) | タンゲレチン及びegcgを含有する皮膚外用剤組成物 | |
| JP2024134554A (ja) | 毛髪ケア活性剤 | |
| BR112019022610B1 (pt) | Utilização cosmética de um extrato de nephelium lappaceum, método de cuidado cosmético, e, uso de um extrato | |
| RU2197945C2 (ru) | ПРИМЕНЕНИЕ ПО МЕНЬШЕЙ МЕРЕ ОДНОГО ЭКСТРАКТА РАСТЕНИЯ ИЗ РОДА Chrysanthemum ДЛЯ СТИМУЛЯЦИИ ПИГМЕНТАЦИИ КОЖИ И/ИЛИ ВОЛОС | |
| US20060272103A1 (en) | Compositions comprising KAP polypeptides | |
| JP2024056871A (ja) | 毛髪化粧料 | |
| JP2007182444A (ja) | ハッカの抽出物の化粧的使用 | |
| CN101087584A (zh) | 能提高黑色素细胞中谷胱甘肽比率的化合物在治疗灰发症中的用途 | |
| BR102023024431A2 (pt) | Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso | |
| WO2024108286A1 (pt) | Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso | |
| BR102023024431B1 (pt) | Composição cosmética para a indução da síntese de melanina em um indivíduo ou animal; processo de produção; método cosmético e uso | |
| JP2006241102A (ja) | Scf遊離抑制剤及び皮膚外用組成物 | |
| BR102023022757A2 (pt) | Compostos e composições farmacêuticas, dermatológicas ou cosméticas para redução da síntese de melanina, estimulação da produção de colágeno tipo i, despigmentação da pele e/ou promover uma ação antienvelhecimento da pele em um indivíduo ou animal, usos e métodos | |
| JP2009249366A (ja) | コラーゲン産生促進剤、及び老化防止用皮膚外用剤 | |
| US20020041908A1 (en) | Iridacea extracts for stimulating the immune system | |
| JP2020152669A (ja) | Slc45a2発現抑制剤 | |
| US10456429B2 (en) | Use of probiotic micro-organisms as an agent that promotes the synthesis of melanin | |
| JP2011207778A (ja) | 皮膚外用剤又は化粧料 | |
| CN115700114A (zh) | 一种抗衰老组合物、其应用及包含该组合物的眼霜 | |
| CN110037949B (zh) | 红毛丹提取物的新美容化妆用途 | |
| CN115554380B (zh) | 一种通过作用于毛囊组织防治脱发的组合物及其用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23892823 Country of ref document: EP Kind code of ref document: A1 |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 202380073489.2 Country of ref document: CN |
|
| WWP | Wipo information: published in national office |
Ref document number: 202380073489.2 Country of ref document: CN |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 2023892823 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| ENP | Entry into the national phase |
Ref document number: 2023892823 Country of ref document: EP Effective date: 20250623 |
|
| WWP | Wipo information: published in national office |
Ref document number: 2023892823 Country of ref document: EP |
